Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X2HK
|
||||
Former ID |
DNC009921
|
||||
Drug Name |
N-{4-[2-(4-Hydroxyphenyl)ethyl]phenyl}phthalimide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530220] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H17NO3
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)N(C2=O)C3=CC=C(C=C3)CCC4=CC=C(C=C4)O
|
||||
InChI |
1S/C22H17NO3/c24-18-13-9-16(10-14-18)6-5-15-7-11-17(12-8-15)23-21(25)19-3-1-2-4-20(19)22(23)26/h1-4,7-14,24H,5-6H2
|
||||
InChIKey |
OFQPQJJVXCUPFR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Oxysterols receptor LXR-alpha | Target Info | Inhibitor | [530220] | |
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.